silybin has been researched along with betadex in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beccarello, A; Crepaldi, G; De Monte, A; Donadon, V; Lirussi, F; Velussi, M; Zanette, G | 1 |
| Bigotto, A; Grassi, M; Passerini, N; Perissutti, B; Voinovich, D | 1 |
| Archontaki, H; Becker-Baldus, J; Chatziathanasiadou, M; Chatzigeorgiou, P; Chatzikonstantinou, AV; Glaubitz, C; Kefala, E; Kellici, TF; Leonis, G; Mavromoustakos, T; Ntountaniotis, D; Papadopoulos, MG; Tzakos, AG; Tzimas, S; Valsami, G; Viras, K | 1 |
| Archontaki, H; Balafas, E; Christodoulou, E; Dokoumetzidis, A; Kechagia, IA; Kostomitsopoulos, N; Tzimas, S; Valsami, G | 1 |
| Dhanaraj, P; Israel, EVMV; Paulraj, MS; Sudha, N; Yousuf, S | 1 |
| Ansari, R; Ehsani, M; Hasanzadeh, M; Jouyban, A; Soleymani, J | 1 |
1 trial(s) available for silybin and betadex
| Article | Year |
|---|---|
Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
Topics: Antioxidants; beta-Cyclodextrins; Blood Glucose; C-Peptide; Cholesterol, HDL; Cyclodextrins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Liver Diseases, Alcoholic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebos; Silybin; Silymarin; Triglycerides | 2002 |
5 other study(ies) available for silybin and betadex
| Article | Year |
|---|---|
Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems.
Topics: Area Under Curve; beta-Cyclodextrins; Biological Availability; Biomechanical Phenomena; Chemical Phenomena; Crystallization; Desiccation; Drug Carriers; Drug Stability; Half-Life; Kinetics; Metabolic Clearance Rate; Particle Size; Plant Extracts; Porosity; Powders; Silybin; Silybum marianum; Silymarin; Solubility; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Surface Properties; Time Factors; X-Ray Diffraction | 2009 |
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Biopharmaceutics; Biophysical Phenomena; Cell Proliferation; Drug Interactions; Humans; Magnetic Resonance Spectroscopy; MCF-7 Cells; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Protective Agents; Silybin; Silymarin; Solubility | 2015 |
Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-β-CD lyophilized product.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intravenous; Administration, Oral; Animals; Antioxidants; beta-Cyclodextrins; Biological Availability; Freeze Drying; Male; Mice, Inbred C57BL; Models, Biological; Silybin; Silymarin; Tissue Distribution | 2015 |
On the accessibility of surface-bound drugs on magnetic nanoparticles. Encapsulation of drugs loaded on modified dextran-coated superparamagnetic iron oxide by β-cyclodextrin.
Topics: Atorvastatin; beta-Cyclodextrins; Dextrans; Drug Compounding; Magnetite Nanoparticles; Magnetometry; Microscopy, Electron, Scanning; Pharmaceutical Preparations; Photoelectron Spectroscopy; Raloxifene Hydrochloride; Silybin; Silymarin; Spectrometry, Fluorescence; Surface Properties; X-Ray Diffraction | 2016 |
Sensitive identification of silibinin as anticancer drug in human plasma samples using poly (β-CD)-AgNPs: A new platform towards efficient clinical pharmacotherapy.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Biosensing Techniques; Electrochemical Techniques; Humans; Metal Nanoparticles; Polymers; Silver; Silybin | 2021 |